Aimmune Therapeutics
8000 Marina Boulevard Suite 300,
Brisbane, 94005, CA,
United States
Brisbane, 94005, CA,
United States
1 650-614-5220
Life Sciences
Aimmune Therapeutics Technographics
Aimmune Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Aimmune Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 500 Aimmune Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Aimmune Therapeutics has purchased the following applications: Intuit Quickbooks Enterprise for ERP Financial in 2013, Rocket.chat for Chatbots and Conversational AI in 2020, Microsoft 365 for Collaboration in 2015 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Aimmune Therapeutics is running and its propensity to invest more and deepen its relationship with Intuit , Oracle , Rocket.chat or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Aimmune Therapeutics revenues, which have grown to $100.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Aimmune Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Aimmune Therapeutics Tech Stack and Enterprise Applications
Aimmune Therapeutics ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Intuit | Legacy | Intuit Quickbooks Enterprise | ERP Financial | ERP | x | 2013 | 2013 |
In 2013 Aimmune Therapeutics deployed Intuit Quickbooks Enterprise as its ERP Financial system to support core finance and accounting functions across the organization. The deployment positioned Intuit Quickbooks Enterprise as the central ledger and reporting engine for accounts payable, accounts receivable, and general ledger processing while aligning transaction capture with a standardized chart of accounts.
Configuration work focused on typical ERP Financial capabilities, including general ledger setup, multi-entity chart of accounts design, accounts payable automation, accounts receivable invoicing and collections workflows, fixed asset tracking, bank reconciliation processes, and financial reporting configuration. Intuit Quickbooks Enterprise was configured to produce period-end financial statements and operational reports, and to enforce accounting periods and posting controls consistent with corporate close requirements.
Operational governance emphasized role based access controls, transaction audit trails, and defined month end close procedures to coordinate finance, accounting, and treasury activities within the United States organization. Aimmune Therapeutics Intuit Quickbooks Enterprise ERP Financial deployment oriented financial process owners toward standardized workflows and centralized bookkeeping, reflecting prior experience with Quick Books and other general ledger and ERP systems.
|
|
|
|
|
ERP Financial | ERP |
|
2017 | 2018 |
|
Aimmune Therapeutics AI-Powered Application
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Rocket.chat | Legacy | Rocket.chat | Chatbots and Conversational AI | AI-Powered Application | n/a | 2020 | 2020 |
In 2020, Aimmune Therapeutics implemented Rocket.chat on its public website as a web-embedded conversational interface. Rocket.chat was deployed to provide customer-facing interaction and automated assistance, and this implementation is classified under the Chatbots and Conversational AI category.
The Rocket.chat implementation emphasizes real-time messaging, automated conversational flows and moderation controls, configured to support visitor engagement and patient support workflows on the corporate site. Governance is centered on administrator configuration panels, role based access for content moderation and scripted conversational content management, aligning operational controls with standard Chatbots and Conversational AI practices.
|
Aimmune Therapeutics Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 Aimmune Therapeutics implemented Microsoft 365 as its Collaboration platform for corporate productivity across the organization, covering approximately 500 employees in the United States. The deployment is recorded on the company website as using Microsoft 365 and positions the application as the primary Collaboration layer for email and document workflows.
Microsoft 365 was configured to provide canonical Collaboration capabilities including hosted email and calendaring, cloud document storage and synchronization, team chat and meetings, and SharePoint based intranet content management. The implementation of Microsoft 365 included configuration of user mailboxes, tenant-level SharePoint site collections, OneDrive provisioning for user file storage, and real-time communication tooling to support cross-functional collaboration.
Operational coverage extended to core business functions aligned with Life Sciences operations, supporting research, clinical, regulatory and commercial groups for internal communication and document sharing. The presence of Microsoft 365 on the corporate website indicates an enterprise SaaS posture for Collaboration services rather than an on premise collaboration stack.
Governance emphasized centralized tenant administration, role based user provisioning, and information architecture for SharePoint and OneDrive to manage content lifecycle and access controls. Rollout activities referenced on the website imply standard migration steps such as account onboarding, mail routing configuration, and end user adoption initiatives to embed Microsoft 365 Collaboration into day to day workflows.
|
Aimmune Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application, Web and Enterprise Search | Content Management |
|
2020 | 2020 |
|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
Aimmune Therapeutics CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2018 | 2018 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2016 | 2016 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2016 | 2016 |
|
Aimmune Therapeutics ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Performance Management | ITSM |
|
2018 | 2018 |
|
|
|
|
|
IT Service Management | ITSM |
|
2021 | 2021 |
|
Aimmune Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Cloud Storage | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
Aimmune Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2018 | 2018 |
|
IT Decision Makers and Key Stakeholders at Aimmune Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Chief Financial Officer | CXO | Finance | |
|
|
|
Chief Executive Officer | CXO | Finance | |
|
|
|
Vice President of Clinical Operations | VP | Operations | |
|
|
|
Chief Operating Officer | CXO | Finance | |
|
|
|
Chief Financial Officer | CXO | Finance | |
|
|
|
Senior Director of Procurement & Strategic Sourcing | Director | Procurement | |
|
|
|
Senior Director, IT Applications G&A | Director | IT | |
|
|
|
Senior Vice President, Global IT & Facilities | VP | IT | |
|
|
|
Sr IT Manager, Finance Systems | Manager | IT | |
|
Apps Being Evaluated by Aimmune Therapeutics Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Aimmune Therapeutics IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Aimmune Therapeutics digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Aimmune Therapeutics Technographics
Aimmune Therapeutics is a Life Sciences organization based in United States,
with around 500 employees and annual revenues of $100.0 million.
Aimmune Therapeutics operates a diverse technology stack with applications such as
Intuit Quickbooks Enterprise, Rocket.chat and Microsoft 365,
covering areas like ERP Financial, Chatbots and Conversational AI and Collaboration.
Aimmune Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Intuit, Rocket.chat and Microsoft.
Aimmune Therapeutics recently adopted applications including
DocuSign eSignature in 2021, ServiceNow ITSM in 2021 and Microsoft Azure Cloud Services in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Aimmune Therapeutics’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Aimmune Therapeutics’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Aimmune Therapeutics technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.